Author: Chue Pierre Chue James
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.13, Iss.11, 2012-08, pp. : 1661-1670
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Olanzapine pamoate for the treatment of schizophrenia
By Naber Dieter
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. :
Drug safety evaluation of olanzapine pamoate
By Schöttle Daniel Kuhnigk Olaf Naber Dieter
Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. :
Olanzapine: a critical review of recent literature
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. :
Olanzapine: A Pharmacoeconomic Review of its Use in Schizophrenia
PharmacoEconomics, Vol. 15, Iss. 6, 1999-06 ,pp. :